Tumor-specific CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

被引：0
|
作者：
Dragovich, Matthew A.
Davra, Viralkumar
Faber, Matthew S.
Kim, Yoon Kyung
Nisthal, Alex
Zeng, Veronica G.
Jacinto, Jonathan
Diaz, Juan E.
Truong, Thuy
Qi, Jing
Avery, Kendra N.
Rashid, Rumana
Lee, Sung-Hyung
Chu, Seung Y.
Bonzon, Christine
Love, Ruschelle
Bernett, Matthew J.
Ernst, James A.
Bahjat, Rena
Barlow, Norman J.
Desjarlais, John R.
Hedvat, Michael
Moore, Gregory L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2983
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2983
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PDL1-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors.
    Moore, Gregory L.
    Zeng, Veronica
    Diaz, Juan
    Bonzon, Christine
    Avery, Kendra N.
    Love, Ruschelle
    Dragovich, Matthew
    Rashid, Rumana
    Hackett, Michael
    Leung, Irene W.
    Qi, Jing
    Bakhit, Charles G.
    Muchhal, Umesh S.
    Barlow, Norman J.
    Desjarlais, John R.
    Hedvat, Michael
    CANCER RESEARCH, 2021, 81 (13)
  • [2] PD-L1 TARGETED CD28 COSTIMULATORY BISPECIFIC ANTIBODIES ENHANCE T CELL ACTIVATION IN SOLID TUMORS
    Zeng, Veronica
    Moore, Gregory
    Diaz, Juan
    Bonzon, Christine
    Avery, Kendra
    Love, Ruschelle
    Dragovich, Matthew
    Rashid, Rumana
    Leung, Irene
    Hackett, Michael
    Qi, Jing
    Bakhit, Charles
    Muchhal, Umesh
    Barlow, Norman
    Desjarlais, John
    Hedvat, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A726 - A726
  • [3] COSTIMULATORY CD28 TRISPECIFIC ANTIBODIES TARGETING PDL1 AND PDL2 ENHANCE T CELL ACTIVATION IN SOLID TUMORS
    Zeng, Veronica
    Diaz, Juan
    Qi, Jing
    Truong, Thuy
    Dragovich, Matthew
    Rashid, Rumana
    Bonzon, Christine
    Lertkiatmongkol, Panida
    Love, Ruschelle
    Hackett, Michael
    Avery, Kendra
    Barlow, Norman
    Desjarlais, John
    Hedvat, Michael
    Moore, Gregory
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1115 - A1115
  • [4] Optimized CD28 bispecific antibodies for targeted activation of T cells within the tumor microenvironment
    Majocchi, Sara
    Lloveras, Pauline
    Burnet-Merlin, Coline
    Nouveau, Lise
    Pleche, Nicolas
    Malinge, Pauline
    Batista, Claudia
    Daviet, Christelle
    Charreton, Maud
    Pontini, Guillemette
    Gueneau, Franck
    Moine, Valery
    Magistrelli, Giovanni
    Shang, Limin
    Ferlin, Walter
    Masternak, Krzysztof
    CANCER RESEARCH, 2022, 82 (12)
  • [5] CD3 × CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation
    An Willems
    Steve Schoonooghe
    Dominique Eeckhout
    Geert De Jaeger
    Johan Grooten
    Nico Mertens
    Cancer Immunology, Immunotherapy, 2005, 54 : 1059 - 1071
  • [6] A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
    Skokos, Dimitris
    Waite, Janelle C.
    Haber, Lauric
    Crawford, Alison
    Hermann, Aynur
    Ullman, Erica
    Slim, Rabih
    Godin, Stephen
    Ajithdoss, Dharani
    Ye, Xuan
    Wang, Bei
    Wu, Qi
    Ramos, Ilyssa
    Pawashe, Arpita
    Canova, Lauren
    Vazzana, Kristin
    Ram, Priyanka
    Herlihy, Evan
    Ahmed, Hassan
    Oswald, Erin
    Golubov, Jacquelynn
    Poon, Patrick
    Havel, Lauren
    Chiu, Danica
    Lazo, Miguel
    Provoncha, Kathleen
    Yu, Kevin
    Kim, Julie
    Warsaw, Jacqueline J.
    Oristian, Nicole Stokes
    Siao, Chia-Jen
    Dudgeon, Drew
    Huang, Tammy
    Potocky, Terra
    Martin, Joel
    MacDonald, Douglas
    Oyejide, Adelekan
    Rafique, Ashique
    Poueymirou, William
    Kirshner, Jessica R.
    Smith, Eric
    Olson, William
    Lin, John
    Thurston, Gavin
    Sleeman, Matthew A.
    Murphy, Andrew J.
    Yancopoulos, George D.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (525)
  • [7] CD3 x CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation
    Willems, A
    Schoonooghe, S
    Eeckhout, D
    De Jaeger, G
    Grooten, J
    Mertens, N
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (11) : 1059 - 1071
  • [8] Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation
    Diehn, M
    Alizadeh, AA
    Rando, OJ
    Liu, CL
    Stankunas, K
    Botstein, D
    Crabtree, GR
    Brown, PO
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) : 11796 - 11801
  • [9] Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28
    Rosenblatt, Jacalyn
    Wu, Zekui
    Vasir, Baldev
    Zarwan, Corrine
    Stone, Richard
    Mills, Heidi
    Friedman, Thea
    Konstantinopoulos, Panagiotis A.
    Spentzos, Dimitrios
    Ghebremichael, Musie
    Stevenson, Kristen
    Neuberg, Donna
    Levine, James D.
    Joyce, Robin
    Tzachanis, Dimitrios
    Boussiotis, Vassiliki
    Kufe, Donald
    Avigan, David
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (02) : 155 - 166
  • [10] Tumor-Specific T Cell Activation in Malignant Brain Tumors
    Mohme, Malte
    Neidert, Marian Christoph
    FRONTIERS IN IMMUNOLOGY, 2020, 11
12345